The Institute of Translational Health Sciences is delighted to announce the 2024 Pilot Award recipients. The Pilot program is designed to inspire innovative and collaborative research aimed at improving overall human health. This year’s awardees were selected from a diverse group of applicants whose research...
This year, we began a new profile series to shed light on some of the distinguished scholars currently participating in our KL2 Program. The first installment profiled someone at the very beginning of their KL2 experience, Dr. Blake Langley. Now, we’re speaking to someone who...
The Institute of Translational Health Sciences is pleased to announce the 2024 cohort of scholars for the ITHS KL2 Multidisciplinary Clinical Research Career Development Program. Benjamin Lidgard, Kristian Jones, Michelle Guignet, and Jonathan An are early career investigators who will be provided with research time,...
The ITHS Pilot program is happy to officially welcome Teddy Johnson as the new co-director of the Pilot Program. He is not new to the team, as he’s been an advisor to the program for several years, specializing in commercial development. Also joining the team...
ITHS, in collaboration with the Andy Hill Cancer Research Endowment CARE Fund, is proud to announce the RADIANT program. This initiative addresses a critical area of need in oncology research: the lack of diversity among participants of cancer clinical trials. Purpose Cancer affects people from all walks...
Written by Kate Stringer via the UW SPH Blog *** Communities and academic researchers must collaborate to improve health equity, but finding each other and aligning goals can be challenging. Researchers at the University of Washington School of Public Health (SPH) and the Institute of Translational Health Sciences...
Making the jump from research to the real-world can be daunting – but not if you have the right tools & training. Enter the Translational Science Entrepreneurship Program (TSEP), a new entrepreneurship-focused training program designed to bridge the gap between scientific discovery and real-world application....
The ITHS interview series is meant to shine a deserving spotlight on individuals who are doing critical work across the vast spectrum of translational science. In this case, we are shining the light on our brilliant KL2 Multidisciplinary Clinical Research Career Development program, as...
Dear Colleagues, I hope this message finds you all in good spirits. For those who may not know me yet, I am John Amory, and it has been my privilege to be a part of the ITHS community for the past 13 years. As I step...
Dr. Mary “Nora” Disis, MD, principal investigator for the Institute of Translational Health Sciences (ITHS) will depart from this position, effective March 1, 2024. She will remain active in several other roles, including as Director of the UW Medicine Cancer Vaccine Institute, where she is...